FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998049182> ?p ?o ?g. }

• W1998049182 endingPage "34" @default.
• W1998049182 startingPage "34" @default.
• W1998049182 abstract "Global views emphasize the need for early; effective intervention against the atherogenic dyslipidemia associated with type 2 diabetes and metabolic syndrome to reduce the risk of premature cardiovascular diseases. Our aim was to determine the clinical practices and compliance among dyslipidemia with type II diabetes and hypertension in multiracial society.Study was carried out in out-patient department of General hospital Penang over a period of ten months (Jan - Oct 2008). Study reflects the retrospective data collection covering a period of three years from Jan 2005 - Dec 2007. Universal sampling technique was used to select all the patients' undergone treatment for diabetes type II and dyslipidemia. All the concerned approvals were obtained from Clinical research Committee (CRC). Data was analyzed by using SPSS 15®.A total of 501 diabetes type 2 patients with dyslipidemia were identified in this study. The demographic data showed that 55.9% (n = 280) were female patients and 44.1% (n = 221) were males. Patients on combination therapy of metformin with other antidiabetic agent were 79%, while 21% were on monotherapy. Lovastatin was received as monotherapy in 83% of study population, while only 17% were on combination with gemfibrozil. Means of FPG and lipid profile were reduced from the initial (2005) to the latest level (2007) significantly (p < 0.001). Only 0.89% decrease in mean weight with S.D 13.1 as compared to initial S.D 12.8 after three years of Cohort. While in description 35.2% representatives gain weight with majority of males (71.5%), 52.3% with weight loss of 1-3 pounds majority (69.3%) with female respondents and rest 12.4% remains with same weight with mix gender distribution.Metformin and lovastatin use among patients of type 2 diabetes and dyslipidemia is significantly improved the clinical outcomes. No significant association of metformin or lovastatin is found against the hypertension. Metformin and calcium channel blocker combination therapy was found to be the best choice in the co-treatment of diabetes and hypertension." @default.
• W1998049182 created "2016-06-24" @default.
• W1998049182 creator A5054936170 @default.
• W1998049182 creator A5076755843 @default.
• W1998049182 creator A5076880250 @default.
• W1998049182 date "2010-01-01" @default.
• W1998049182 modified "2023-09-26" @default.
• W1998049182 title "Clinical evaluation of Dyslipidemia among type II diabetic patients at Public hospital Penang, Malaysia" @default.
• W1998049182 cites W1625701728 @default.
• W1998049182 cites W1893959718 @default.
• W1998049182 cites W1971783155 @default.
• W1998049182 cites W1978339749 @default.
• W1998049182 cites W1979409787 @default.
• W1998049182 cites W1996441843 @default.
• W1998049182 cites W2022305048 @default.
• W1998049182 cites W2027275601 @default.
• W1998049182 cites W2037722260 @default.
• W1998049182 cites W2041166009 @default.
• W1998049182 cites W2044322367 @default.
• W1998049182 cites W2048878760 @default.
• W1998049182 cites W2053280779 @default.
• W1998049182 cites W2055769770 @default.
• W1998049182 cites W2056622903 @default.
• W1998049182 cites W2078508655 @default.
• W1998049182 cites W2087523820 @default.
• W1998049182 cites W2125191390 @default.
• W1998049182 cites W2146901298 @default.
• W1998049182 cites W2153449155 @default.
• W1998049182 cites W2164346577 @default.
• W1998049182 cites W2165199707 @default.
• W1998049182 cites W2170760052 @default.
• W1998049182 cites W2188846692 @default.
• W1998049182 cites W2271771390 @default.
• W1998049182 cites W2275139239 @default.
• W1998049182 cites W2279761563 @default.
• W1998049182 cites W2337454357 @default.
• W1998049182 cites W2402258293 @default.
• W1998049182 cites W2403113238 @default.
• W1998049182 cites W2412345970 @default.
• W1998049182 cites W2417503814 @default.
• W1998049182 cites W2769264260 @default.
• W1998049182 cites W46273423 @default.
• W1998049182 cites W571388160 @default.
• W1998049182 cites W85668126 @default.
• W1998049182 cites W113781026 @default.
• W1998049182 cites W2599300992 @default.
• W1998049182 doi "https://doi.org/10.1186/1755-7682-3-34" @default.
• W1998049182 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3002890" @default.
• W1998049182 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21092333" @default.
• W1998049182 hasPublicationYear "2010" @default.
• W1998049182 type Work @default.
• W1998049182 sameAs 1998049182 @default.
• W1998049182 citedByCount "1" @default.
• W1998049182 countsByYear W19980491822019 @default.
• W1998049182 crossrefType "journal-article" @default.
• W1998049182 hasAuthorship W1998049182A5054936170 @default.
• W1998049182 hasAuthorship W1998049182A5076755843 @default.
• W1998049182 hasAuthorship W1998049182A5076880250 @default.
• W1998049182 hasBestOaLocation W19980491821 @default.
• W1998049182 hasConcept C126322002 @default.
• W1998049182 hasConcept C134018914 @default.
• W1998049182 hasConcept C187212893 @default.
• W1998049182 hasConcept C2777180221 @default.
• W1998049182 hasConcept C2778096610 @default.
• W1998049182 hasConcept C2778163477 @default.
• W1998049182 hasConcept C2778670441 @default.
• W1998049182 hasConcept C2780323712 @default.
• W1998049182 hasConcept C2780578515 @default.
• W1998049182 hasConcept C2908647359 @default.
• W1998049182 hasConcept C511355011 @default.
• W1998049182 hasConcept C555293320 @default.
• W1998049182 hasConcept C71924100 @default.
• W1998049182 hasConcept C99454951 @default.
• W1998049182 hasConceptScore W1998049182C126322002 @default.
• W1998049182 hasConceptScore W1998049182C134018914 @default.
• W1998049182 hasConceptScore W1998049182C187212893 @default.
• W1998049182 hasConceptScore W1998049182C2777180221 @default.
• W1998049182 hasConceptScore W1998049182C2778096610 @default.
• W1998049182 hasConceptScore W1998049182C2778163477 @default.
• W1998049182 hasConceptScore W1998049182C2778670441 @default.
• W1998049182 hasConceptScore W1998049182C2780323712 @default.
• W1998049182 hasConceptScore W1998049182C2780578515 @default.
• W1998049182 hasConceptScore W1998049182C2908647359 @default.
• W1998049182 hasConceptScore W1998049182C511355011 @default.
• W1998049182 hasConceptScore W1998049182C555293320 @default.
• W1998049182 hasConceptScore W1998049182C71924100 @default.
• W1998049182 hasConceptScore W1998049182C99454951 @default.
• W1998049182 hasIssue "1" @default.
• W1998049182 hasLocation W19980491821 @default.
• W1998049182 hasLocation W19980491822 @default.
• W1998049182 hasLocation W19980491823 @default.
• W1998049182 hasLocation W19980491824 @default.
• W1998049182 hasOpenAccess W1998049182 @default.
• W1998049182 hasPrimaryLocation W19980491821 @default.
• W1998049182 hasRelatedWork W1704891933 @default.
• W1998049182 hasRelatedWork W1963884181 @default.
• W1998049182 hasRelatedWork W2007805455 @default.
• W1998049182 hasRelatedWork W2082415271 @default.

• next